Ulrika Morris Selected Research

Infections

2/2021	Influence of cytochrome P450 (CYP) 2C8 polymorphisms on the efficacy and tolerability of artesunate-amodiaquine treatment of uncomplicated Plasmodium falciparum malaria in Zanzibar.
6/2020	Surveillance of genetic markers associated with Plasmodium falciparum resistance to artemisinin-based combination therapy in Pakistan, 2018-2019.
12/2018	Absence of Plasmodium falciparum K13 Propeller Domain Polymorphisms among Field Isolates Collected from the Brazilian Amazon Basin between 1984 and 2011.
10/2013	Usefulness of Plasmodium falciparum-specific rapid diagnostic tests for assessment of parasite clearance and detection of recurrent infections after artemisinin-based combination therapy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ulrika Morris Research Topics

Disease

12	Malaria 01/2022 - 09/2012
6	Falciparum Malaria (Plasmodium falciparum Malaria) 01/2022 - 03/2013
4	Infections 02/2021 - 10/2013
2	Reinfection 02/2021 - 10/2013

Drug/Important Bio-Agent (IBA)

5	artemisinin (artemisinine)IBA 01/2022 - 09/2012
4	Lumefantrine Drug Combination Artemether (Coartem)FDA Link 06/2020 - 10/2013
2	ArtesunateIBA 02/2021 - 01/2020
2	Amodiaquine (Camoquin)FDA Link 02/2021 - 01/2020
2	DNA (Deoxyribonucleic Acid)IBA 01/2017 - 03/2013
1	Antimalarials (Antimalarial Agents)IBA 01/2022
1	Cytochrome P-450 CYP2C8IBA 02/2021
1	Cytochrome P-450 Enzyme System (Cytochrome P450)IBA 02/2021
1	Primaquine FDA Link 06/2020
1	Chloroquine (Aralen)FDA LinkGeneric 06/2020
1	Lumefantrine FDA Link 06/2020
1	2- methyl- 3- (4- phenylpiperidino)propionohydroxamic acid hydrochloride (K 76)IBA 06/2020
1	Cytochromes b (Cytochrome b)IBA 01/2015
1	SYBR Green IIBA 01/2015
1	AntigensIBA 10/2013

Therapy/Procedure

5	Therapeutics 01/2022 - 09/2012
1	Drug Therapy (Chemotherapy) 02/2021
1	Mass Drug Administration 12/2018